HRSA's updated guidelines now recommend self-collection of high-risk HPV specimens for cervical cancer screening for average-risk patients aged 30 to 65.
Most private health insurers will cover cervical cancer screening services without cost-sharing starting January 1, 2027, under Section 2713 of the Public Health Service Act.
The guidelines maintain existing screening protocols, with cervical cytology every 3 years for patients aged 21 to 29 and primary hrHPV testing every 5 years for those aged 30 to 65.
Self-collection aims to improve screening access and reduce discomfort, particularly for patients in rural areas or those facing barriers to traditional screening.
The self-collection option is limited to average-risk patients and excludes those with specific health conditions, emphasizing the need for FDA-approved tests.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise:
